Medical Writing Good Pharma Journal Watch
mew-150pxjpg

Volume 22, Issue 4 - Good Pharma

Journal Watch

Abstract

The August 2013 issue of European Science Editing (ESE), the journal of the European Association of Science Editors, included a couple of articles relating to the San Francisco Declaration on Research Assessment, on which I comment elsewhere in this issue of MEW (see page 273). Briefly, the Declaration aims to change the way in which research is judged, challenging the reliance on the journal impact factor (IF)

References

  1. Marx W. Journal Impact Factor: “the poor man's citation analysis” and alternative approaches. Eur Sci Editing. 2013;39(3):62–3.
  2. Bornmann L, Marx W. Evaluating individual researchers’ performance. Eur Sci Editing. 2013;39(2):39–40.
  3. Steen RG. Journal Impact Factor: baby and bathwater discarded? Eur Sci Editing. 2013;39(3):64–5.
  4. Allen L, Jones C, Dolby K, Lynn D, Walport M. Looking for landmarks: the role of expert review and bibliometric analysis in evaluating scientific publication outputs. PLoS One. 2009;4(6):e5910.
  5. Pinto N. Common errors to look out for in medical papers. Eur Sci Editing. 2013;39(3):68–9.
  6. Fonseca M. Does an academic copy-editor require knowledge of statistics? Eur Sci Editing. 2013;39(2):46.
  7. Baždarić K. Patchwork plagiarism. Eur Sci Editing. 2013;39(2):32–3.
  8. Steen RG. Authorship: to be or not to be? Eur Sci Editing. 2013;39(1):6–8.
  9. Wheatley D. On the current presentation of scientific papers: 2. Cutting out clichés. Eur Sci Editing. 2013;39(1):13.
  10. Ahmed HS, Gasparyan AY. Criticism of peer review and ways to improve it. Eur Sci Editing. 2013;39(1):8–10.

Search

Articles

Good pharma
Message from the President
Transparency and the healthcare industry: The Sun is shining
Sunshine spreading across the Atlantic and over Europe
Bad karma
If a misinformed voice speaks out in the wilderness and no one refutes it, does it make a sound? A call to advocacy
The Big Pharma conspiracy theory
Editorial: Pharmaism
Legal remedies for medical ghostwriting: Imposing fraud liability on guest authors of ghostwritten articles
A decade of change: A new ISMPP has arrived
Selling evidence over the counter: Do community pharmacists engage with evidence-based medicine?
Good regulatory practice and the role(s) of a regulatory affairs professional
Profile: An interview with Dr Gustavo A. Silva on the concept of public health in medical writing and translation
AuthorAID: An international service and chance to serve
India as a hub for ethical and evidence-based medical communications
Providing value for medicines in older people
In the Bookstores
Journal Watch
The Webscout
Regulatory Writing
Medical Communications
Manuscript Writing
Out On Our Own
Erratum
The Light Stuff

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: